Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Common Stock Repurchased

Cash spent buying back the company's own shares.

No reported Common Stock Repurchased figures are available to summarize.

Common Stock Repurchased history

Currency unavailable · from the cash flow

No Common Stock Repurchased data reported for this period type.

Common Stock Repurchased vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Common Stock Repurchased for LTGO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PCRXPacira BioSciences, Inc.LTM Mar 2026$198.37M USD+693.5%—27.0%
COLLCollegium Pharmaceutical, Inc.LTM Mar 2026$25.1M USD-58.2%+21.3%3.2%
SCLXScilex Holding CompanyLTM Mar 2026$0 USD+100.0%—0.0%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —+100.0%+21.3%3.2%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.